Study supports wider use of FDA-approved drug for rare muscle disease

Updated on: December 20,2025

Study supports wider use of FDA-approved drug for rare muscle disease

Updated on:December 20,2025

Review finds no link between acetaminophen use in pregnancy and neurodevelopmental disorders

Updated on: December 21,2025

Review finds no link between acetaminophen use in pregnancy and neurodevelopmental disorders

Updated on:December 21,2025

Aspirin therapy proves ineffective in treating chronic rhinosinusitis with nasal polyps

Updated on: September 30,2025

Aspirin therapy proves ineffective in treating chronic rhinosinusitis with nasal polyps

Updated on:September 30,2025

Peristaltic pump flow: A potential trigger for amyloid protein aggregation

Updated on: March 30,2025

Peristaltic pump flow: A potential trigger for amyloid protein aggregation

Updated on:March 30,2025

Natural protein drug may slow neuron death linked to Alzheimer's disease

byUniversity of Colorado AnschutzCredit: Public DomainScientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may begin in early life, a

Updated on: January 31,2026

Natural protein drug may slow neuron death linked to Alzheimer's disease

byUniversity of Colorado AnschutzCredit: Public DomainScientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may begin in early life, a

Updated on:January 31,2026

Extensive sequencing study finds few links between cancer and microbiome

Updated on: October 07,2025

Extensive sequencing study finds few links between cancer and microbiome

Updated on:October 07,2025

Novel drug combination offers hope for men with advanced prostate cancer

Updated on: November 02,2025

Novel drug combination offers hope for men with advanced prostate cancer

Updated on:November 02,2025

FDA approves Waskyra for Wiskott-Aldrich syndrome

by Lori SolomonThe U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).Waskyra is

Updated on: December 27,2025

FDA approves Waskyra for Wiskott-Aldrich syndrome

by Lori SolomonThe U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).Waskyra is

Updated on:December 27,2025

Cancer outcomes in Australia are improving overall

Updated on: November 06,2025

Cancer outcomes in Australia are improving overall

Updated on:November 06,2025

RNA molecule identified as possible driver of gastric cancer

Updated on: April 21,2025

RNA molecule identified as possible driver of gastric cancer

Updated on:April 21,2025